References
- Beecher, H. K., (1955). The powerful placebo. J. Amer. med. Ass., 159, 1602.1. Beecher, H. K., (1955). The powerful placebo. J. Amer. med. Ass., 159, 1602.
- Kerry, R. J., McDermott, C. M., and Orme, J. E., (1974). Bromazepam, medazepam, chlor-diazepoxide in treatment of neurotic anxiety. Brit. J. Psychiat., 124, 485.2. Kerry, R. J., McDermott, C. M., and Orme, J. E., (1974). Bromazepam, medazepam, chlor-diazepoxide in treatment of neurotic anxiety. Brit. J. Psychiat., 124, 485.
- McLeod, W. R., Mowbray, R. M., and Davies, B., (1970). Trials of RO 5/3350 and diazepam for anxiety symptoms. Clin. Pharm. Therap., 11, 856.3. McLeod, W. R., Mowbray, R. M., and Davies, B., (1970). Trials of RO 5/3350 and diazepam for anxiety symptoms. Clin. Pharm. Therap., 11, 856.
- Nakahara, T., et al., (1973). Pharmacological studies of bromazepam. Acta med. (Fukuoka), 43, 27.4. Nakahara, T., et al., (1973). Pharmacological studies of bromazepam. Acta med. (Fukuoka), 43, 27.
- Ueki, S., et al., (1973). Behavioural pharmacology of bromazepam (RO 5/3350). Acta. med. (Fukuoka), 43, 41.5. Ueki, S., et al., (1973). Behavioural pharmacology of bromazepam (RO 5/3350). Acta. med. (Fukuoka), 43, 41.
- Zbinden, G., and Randall, L. O., (1967). Pharmacology of the benzodiazepines: laboratory and clinical correlation. In “Advances in Pharmacology”, 5, 213. Academic Press, New York.6. Zbinden, G., and Randall, L. O., (1967). Pharmacology of the benzodiazepines: laboratory and clinical correlation. In “Advances in Pharmacology”, 5, 213. Academic Press, New York.